Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue

Janet M. Chiang, George Kaysen, Anne L. Schafer, Cynthia Delgado, Kirsten L. Johansen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Fibroblast growth factor 23 (FGF-23) may be involved in signaling between bone and adipose tissue in dialysis patients, but its role is uncertain. We sought to examine the association between FGF-23 and adiposity and whether this association is mediated in part by leptin. Design/Setting: We performed univariate and multivariate linear regression analyses using data from 611 participants in a cohort of prevalent hemodialysis patients recruited from dialysis centers in Atlanta, GA and San Francisco, CA from 2009 to 2011. We also investigated the role of leptin in these relationships. Subjects: Participants were aged ≥18 years, English or Spanish speaking, and receiving hemodialysis for at least 3 months. Main Outcome Measures: Outcome measures of adiposity included body mass index, waist circumference, and body fat measured by bioelectrical impedance spectroscopy. Results: Mean age was 56 ± 14 years, 39.8% were female, and median serum FGF-23 was 807 pg/mL. In fully adjusted models, FGF-23 was inversely associated with body mass index (−0.24 kg/m2 per 50% higher FGF-23, 95% confidence interval [CI]: −0.38 to −0.10), waist circumference (−0.44 cm per 50% higher FGF-23, 95% CI: −0.79 to −0.08), and percent body fat (−0.58% per 50% higher FGF-23, 95% CI: −0.79 to −0.37). Leptin was inversely associated with FGF-23. Addition of leptin to body composition models attenuated the associations between FGF-23 and measures of adiposity, but FGF-23 remained significantly associated with percent body fat (−0.17% per 50% higher FGF-23, 95% CI: −0.32 to −0.02). Conclusion: We found a negative association between FGF-23 and adiposity that appears to be mediated in part by leptin. As adipose tissue provides a “protective energy depot” for patients with chronic illness, a decrease in adipose tissue may be one mechanism in which higher FGF-23 levels may contribute to increased mortality in dialysis patients.

Original languageEnglish (US)
JournalJournal of Renal Nutrition
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Adiposity
Renal Dialysis
Adipose Tissue
Bone and Bones
Leptin
Confidence Intervals
Dialysis
Waist Circumference
fibroblast growth factor 23
Body Mass Index
Outcome Assessment (Health Care)
Dielectric Spectroscopy
San Francisco
Body Composition
Electric Impedance
Linear Models
Chronic Disease
Regression Analysis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Cite this

Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis : Possible Cross Talk Between Bone and Adipose Tissue. / Chiang, Janet M.; Kaysen, George; Schafer, Anne L.; Delgado, Cynthia; Johansen, Kirsten L.

In: Journal of Renal Nutrition, 01.01.2018.

Research output: Contribution to journalArticle

@article{f6e53844137a4b1899c851076ff49a93,
title = "Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue",
abstract = "Objective: Fibroblast growth factor 23 (FGF-23) may be involved in signaling between bone and adipose tissue in dialysis patients, but its role is uncertain. We sought to examine the association between FGF-23 and adiposity and whether this association is mediated in part by leptin. Design/Setting: We performed univariate and multivariate linear regression analyses using data from 611 participants in a cohort of prevalent hemodialysis patients recruited from dialysis centers in Atlanta, GA and San Francisco, CA from 2009 to 2011. We also investigated the role of leptin in these relationships. Subjects: Participants were aged ≥18 years, English or Spanish speaking, and receiving hemodialysis for at least 3 months. Main Outcome Measures: Outcome measures of adiposity included body mass index, waist circumference, and body fat measured by bioelectrical impedance spectroscopy. Results: Mean age was 56 ± 14 years, 39.8{\%} were female, and median serum FGF-23 was 807 pg/mL. In fully adjusted models, FGF-23 was inversely associated with body mass index (−0.24 kg/m2 per 50{\%} higher FGF-23, 95{\%} confidence interval [CI]: −0.38 to −0.10), waist circumference (−0.44 cm per 50{\%} higher FGF-23, 95{\%} CI: −0.79 to −0.08), and percent body fat (−0.58{\%} per 50{\%} higher FGF-23, 95{\%} CI: −0.79 to −0.37). Leptin was inversely associated with FGF-23. Addition of leptin to body composition models attenuated the associations between FGF-23 and measures of adiposity, but FGF-23 remained significantly associated with percent body fat (−0.17{\%} per 50{\%} higher FGF-23, 95{\%} CI: −0.32 to −0.02). Conclusion: We found a negative association between FGF-23 and adiposity that appears to be mediated in part by leptin. As adipose tissue provides a “protective energy depot” for patients with chronic illness, a decrease in adipose tissue may be one mechanism in which higher FGF-23 levels may contribute to increased mortality in dialysis patients.",
author = "Chiang, {Janet M.} and George Kaysen and Schafer, {Anne L.} and Cynthia Delgado and Johansen, {Kirsten L.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1053/j.jrn.2017.12.010",
language = "English (US)",
journal = "Journal of Renal Nutrition",
issn = "1051-2276",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis

T2 - Possible Cross Talk Between Bone and Adipose Tissue

AU - Chiang, Janet M.

AU - Kaysen, George

AU - Schafer, Anne L.

AU - Delgado, Cynthia

AU - Johansen, Kirsten L.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Fibroblast growth factor 23 (FGF-23) may be involved in signaling between bone and adipose tissue in dialysis patients, but its role is uncertain. We sought to examine the association between FGF-23 and adiposity and whether this association is mediated in part by leptin. Design/Setting: We performed univariate and multivariate linear regression analyses using data from 611 participants in a cohort of prevalent hemodialysis patients recruited from dialysis centers in Atlanta, GA and San Francisco, CA from 2009 to 2011. We also investigated the role of leptin in these relationships. Subjects: Participants were aged ≥18 years, English or Spanish speaking, and receiving hemodialysis for at least 3 months. Main Outcome Measures: Outcome measures of adiposity included body mass index, waist circumference, and body fat measured by bioelectrical impedance spectroscopy. Results: Mean age was 56 ± 14 years, 39.8% were female, and median serum FGF-23 was 807 pg/mL. In fully adjusted models, FGF-23 was inversely associated with body mass index (−0.24 kg/m2 per 50% higher FGF-23, 95% confidence interval [CI]: −0.38 to −0.10), waist circumference (−0.44 cm per 50% higher FGF-23, 95% CI: −0.79 to −0.08), and percent body fat (−0.58% per 50% higher FGF-23, 95% CI: −0.79 to −0.37). Leptin was inversely associated with FGF-23. Addition of leptin to body composition models attenuated the associations between FGF-23 and measures of adiposity, but FGF-23 remained significantly associated with percent body fat (−0.17% per 50% higher FGF-23, 95% CI: −0.32 to −0.02). Conclusion: We found a negative association between FGF-23 and adiposity that appears to be mediated in part by leptin. As adipose tissue provides a “protective energy depot” for patients with chronic illness, a decrease in adipose tissue may be one mechanism in which higher FGF-23 levels may contribute to increased mortality in dialysis patients.

AB - Objective: Fibroblast growth factor 23 (FGF-23) may be involved in signaling between bone and adipose tissue in dialysis patients, but its role is uncertain. We sought to examine the association between FGF-23 and adiposity and whether this association is mediated in part by leptin. Design/Setting: We performed univariate and multivariate linear regression analyses using data from 611 participants in a cohort of prevalent hemodialysis patients recruited from dialysis centers in Atlanta, GA and San Francisco, CA from 2009 to 2011. We also investigated the role of leptin in these relationships. Subjects: Participants were aged ≥18 years, English or Spanish speaking, and receiving hemodialysis for at least 3 months. Main Outcome Measures: Outcome measures of adiposity included body mass index, waist circumference, and body fat measured by bioelectrical impedance spectroscopy. Results: Mean age was 56 ± 14 years, 39.8% were female, and median serum FGF-23 was 807 pg/mL. In fully adjusted models, FGF-23 was inversely associated with body mass index (−0.24 kg/m2 per 50% higher FGF-23, 95% confidence interval [CI]: −0.38 to −0.10), waist circumference (−0.44 cm per 50% higher FGF-23, 95% CI: −0.79 to −0.08), and percent body fat (−0.58% per 50% higher FGF-23, 95% CI: −0.79 to −0.37). Leptin was inversely associated with FGF-23. Addition of leptin to body composition models attenuated the associations between FGF-23 and measures of adiposity, but FGF-23 remained significantly associated with percent body fat (−0.17% per 50% higher FGF-23, 95% CI: −0.32 to −0.02). Conclusion: We found a negative association between FGF-23 and adiposity that appears to be mediated in part by leptin. As adipose tissue provides a “protective energy depot” for patients with chronic illness, a decrease in adipose tissue may be one mechanism in which higher FGF-23 levels may contribute to increased mortality in dialysis patients.

UR - http://www.scopus.com/inward/record.url?scp=85044505331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044505331&partnerID=8YFLogxK

U2 - 10.1053/j.jrn.2017.12.010

DO - 10.1053/j.jrn.2017.12.010

M3 - Article

C2 - 29606304

AN - SCOPUS:85044505331

JO - Journal of Renal Nutrition

JF - Journal of Renal Nutrition

SN - 1051-2276

ER -